These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6696809)

  • 1. The QT interval: a predictor of the plasma and myocardial concentrations of amiodarone.
    Debbas NM; du Cailar C; Bexton RS; Demaille JG; Camm AJ; Puech P
    Br Heart J; 1984 Mar; 51(3):316-20. PubMed ID: 6696809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QT interval: predictor of the plasma and myocardial concentrations of amiodarone.
    Brown AK; Wiersum JC; Anderson V
    Br Heart J; 1984 Aug; 52(2):240. PubMed ID: 6743443
    [No Abstract]   [Full Text] [Related]  

  • 3. [The Master test in the evaluation of angina patients treated with amiodarone].
    Vincenzi M; Allegri P; De Lio U
    Minerva Cardioangiol; 1976 Dec; 2Y(12):855-62. PubMed ID: 1012465
    [No Abstract]   [Full Text] [Related]  

  • 4. Amiodarone and N-desethylamiodarone concentrations in plasma, red blood cells, and myocardium after a single oral dose: relation to hemodynamic effects in surgical patients.
    Escoubet B; Jaillon P; Berger Y; Commin P; Menasché P; Piwnica A; Echter E
    Am Heart J; 1986 Feb; 111(2):280-5. PubMed ID: 3946169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial disposition of amiodarone in the dog.
    Latini R; Connolly SJ; Kates RE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):603-8. PubMed ID: 6827483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Electrophysiologic effect of intravenous amiodarone on patients with paroxysmal supraventricular tachycardia].
    Li ZC; Shi YS; Huang TG
    Zhonghua Nei Ke Za Zhi; 1985 Jun; 24(6):339-43, 381. PubMed ID: 4017749
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics of amiodarone, desethylamiodarone and other iodine-containing amiodarone metabolites.
    Stäubli M; Troendle A; Schmid B; Balmer P; Kohler B; Studer H; Bircher J
    Eur J Clin Pharmacol; 1985; 29(4):417-23. PubMed ID: 4092724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Electrophysiologic studies on tachycardia with dual A-V nodal pathway reentry and the effects of amiodarone].
    Wu N; Jin L; Yu GM
    Zhonghua Xin Xue Guan Bing Za Zhi; 1985 Mar; 13(1):10-3, 76-7. PubMed ID: 4006696
    [No Abstract]   [Full Text] [Related]  

  • 9. The relationship between the QT interval and plasma amiodarone concentration in patients on long-term therapy.
    Burgess CD; Siebers RW; Purdie GL; Taylor C; Maling TJ
    Eur J Clin Pharmacol; 1987; 33(2):115-8. PubMed ID: 3691605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic studies of amiodarone and its active N-desethyl metabolite.
    Nattel S
    J Cardiovasc Pharmacol; 1986; 8(4):771-7. PubMed ID: 2427817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, antiarrhythmic effects, and tissue concentrations of amiodarone and desethylamiodarone in dogs with acute coronary artery occlusion.
    Somani P; Simon VA; McManus K
    Can J Cardiol; 1985 Jan; 1(1):56-65. PubMed ID: 3850764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Trans-placental passage of amiodarone: electrocardiographic evidence and pharmacological findings in a newborn infant].
    Candelpergher G; Buchberger R; Suzzi G; Padrini R
    G Ital Cardiol; 1982; 12(1):79-82. PubMed ID: 7128995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and myocardial kinetics of amiodarone and its deethyl metabolite after intravenous administration in rabbits.
    Kannan R; Ikeda N; Wagner R; Drachenberg M; Singh BN
    J Pharm Sci; 1984 Sep; 73(9):1208-11. PubMed ID: 6491937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of cardiac and plasma drug levels during long-term amiodarone therapy.
    Debbas NM; Du Cailar C; Sassine A; Derancourt J; Demaille JG; Puech P
    Eur J Clin Invest; 1983 Apr; 13(2):123-7. PubMed ID: 6409635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Amiodarone in the control of supraventricular tachyarrhythmias].
    Molina L; Heredia P; Pinto R; Mesa A; Villarreal A; Gutiérrez Fuster E
    Arch Inst Cardiol Mex; 1983; 53(1):13-6. PubMed ID: 6191726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical use of Cordarone].
    Preobrazhenskiĭ DV; Ryndina MG; Blizniak GV
    Kardiologiia; 1979 Apr; 19(4):107-12. PubMed ID: 35642
    [No Abstract]   [Full Text] [Related]  

  • 17. [Electrophysiologic and clinical effects of amiodarone in patients with paroxysmal atrial tachycardia without ventricular pre-excitation].
    Lukl J
    Vnitr Lek; 1987 Apr; 33(4):313-23. PubMed ID: 3590629
    [No Abstract]   [Full Text] [Related]  

  • 18. Amiodarone-induced ventricular tachycardia.
    Westveer DC; Gadowski GA; Gordon S; Timmis GC
    Ann Intern Med; 1982 Oct; 97(4):561-2. PubMed ID: 7125414
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics and body distribution of amiodarone in man.
    Plomp TA; van Rossum JM; Robles de Medina EO; van Lier T; Maes RA
    Arzneimittelforschung; 1984; 34(4):513-20. PubMed ID: 6540111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Amiodarone in paroxysmal supra-ventricular tachycardias associated with sinus bradycardia].
    Conte MR; Gaita F; Mangiardi L; Asteggiano R; Rosettani E; Brusca A
    Arch Mal Coeur Vaiss; 1983 Oct; 76(10):1204-11. PubMed ID: 6418098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.